Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

9 April 2019

CANTAB Connect used to advance research into postoperative conditions

We’re delighted to announce that CANTAB Connect – our cognitive research platform validated by use in over 2,100 published papers - is being used by Europe’s largest university clinic, Charité – Universitätsmedizin Berlin, for the assessment of long-term cognitive outcomes in clinical studies on patients scheduled for elective surgery.

In 2013 the Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine commonly founded the Berlin Institute of Health.

The Berlin Institute of Health (BIH) aims to restore and maintain people’s quality of life by advancing health-oriented translational sciences that support innovative and interdisciplinary projects leading to better predictive outcomes and improved therapies for progressive diseases and unmet medical needs. This support is provided by BIH Clinical Research Units (CRUs) and available to over 800 investigator-initiated trials run by MDC and Charité Researchers every year. The BIH CRUs coordinate and allocate expertise, state-of-the-art technology, and structures required to help successfully implement and complete clinical trials in accordance with highest quality standards. The BIH CRUs focus heavily on providing expertise in and harmonization of deep-phenotyping services relevant to a wide range of disease entities for both local and multi-center international trials. Central deep-phenotyping services provided to BIH researchers presently address the domains of Physical, Nutritional, Sensory and Cognitive assessment. For cognitive assessments, the CANTAB Connect system was identified as a system that meets BIH CRU prerequisites and has been included in the consultative services provided to BIH researchers by Dr. Nadine Kuelzow.

Please visit: www.bihealth.org/en/research/clinical-research-unit

The Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK) Charité – Universitätsmedizin Berlin uses CANTAB for the assessment of long-term cognitive outcome in clinical studies on patients scheduled for elective surgery. Our goal is to strengthen research collaborations and to consent on methodology in clinical studies focused on Postoperative Delirium (POD), Postoperative Cognitive Dysfunction (POCD) and Post Intensive Care Syndrome (PICS).

Please visit: www.biocog.eu; www.leopoldina.org/veranstaltungen/veranstaltung/event/2455/

 

Find out more

Tags : cognitive research | postoperative conditions | cantab testimonial